Development of an Antiviral Medicinal Plant and Natural Product Database (avMpNp Database) from Biodiversity

The construction of compound databases (DB) is a strategy for the rational search of bioactive compounds and drugs for new and old diseases. In order to bring greater impact to drug discovery, we propose the development of a DB of bioactive antiviral compounds. Several research groups have presented evidence of the antiviral activity of medicinal plants and compounds isolated from these plants. We believe that compiling these discoveries in a DB would benefit the scientific research community and increase the speed to discover new potential drugs and medicines. Thus, we present the Antiviral Medicinal Plant and Natural Product DB (avMpNp DB) as an important source for acquiring, organizing, and distributing knowledge related to natural products and antiviral drug discovery. The avMpNp DB contains a series of chemically diverse compounds with drug-like profiles. To test the potential of this DB, SARS-CoV-2 M<sup>pro</sup> and PL<sup>pro</sup> enzymatic inhibition assays were performed for available compounds resulting in IC<sub>50</sub> values ranging from 6.308±0.296 to 15.795±0.155 μM. As a perspective, artificial intelligence tools will be added to implement computational predictions, as well as other chemical functionalities that allow data validation.

Authors

Institutions

Publication Details

Journal
Chemistry & Biodiversity
Published
2024-11-15
DOI
https://doi.org/10.1002/cbdv.202400285
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development of an Antiviral Medicinal Plant and Natural Product Database (avMpNp Database) from Biodiversity

Vinícius Gonçalves Maltarollo, Alessandra Faria-Campos, Anthony J. O’Donoghue, Ruídonaldo da Costa Brito dos Reis et al.
Chemistry & Biodiversity
Computational Drug Discovery Methods
article

Development of an Antiviral Medicinal Plant and Natural Product Database (avMpNp Database) from Biodiversity

Vinícius Gonçalves Maltarollo, Alessandra Faria-Campos, Anthony J. O’Donoghue, Ruídonaldo da Costa Brito dos Reis, Rachel Oliveira Castilho, Gustavo Moura, Sérgio Rodrigo Vale, Paulo Henrique Otoni Ribeiro, Mateus Sá Magalhães Serafim, Thaís Helena Maciel Fernandes, Daniela Quadros de Azevedo, João Vinícius Vieira Nóia, Ana Claudia Siqueira De Souza, P.M.M. Mendes, Yasmim Carla M. Ribeiro, Sofia Carpini Mermejo
article en

Abstract

The construction of compound databases (DB) is a strategy for the rational search of bioactive compounds and drugs for new and old diseases. In order to bring greater impact to drug discovery, we propose the development of a DB of bioactive antiviral compounds. Several research groups have presented evidence of the antiviral activity of medicinal plants and compounds isolated from these plants. We believe that compiling these discoveries in a DB would benefit the scientific research community and increase the speed to discover new potential drugs and medicines. Thus, we present the Antiviral Medicinal Plant and Natural Product DB (avMpNp DB) as an important source for acquiring, organizing, and distributing knowledge related to natural products and antiviral drug discovery. The avMpNp DB contains a series of chemically diverse compounds with drug-like profiles. To test the potential of this DB, SARS-CoV-2 M<sup>pro</sup> and PL<sup>pro</sup> enzymatic inhibition assays were performed for available compounds resulting in IC<sub>50</sub> values ranging from 6.308±0.296 to 15.795±0.155 μM. As a perspective, artificial intelligence tools will be added to implement computational predictions, as well as other chemical functionalities that allow data validation.

Chemistry & BiodiversityVol. 21(12)
Universidade Federal de Minas Gerais (BR), Universidade Federal do Rio Grande do Sul (BR), University of California San Diego (US), University of Montana (US)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado de Minas Gerais, Universidade Federal de Minas Gerais
Openalex Percentile: Top 76%
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.